Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 NOK)

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

GlaxoSmithKline Pharma A/S

Closing information (x1000 NOK)

Closing information 2024/12 2023/12 2022/12
Turnover 870,935 Less Arrow 715,615 Less Arrow 623,239
Earnings before taxes 25,828 Less Arrow 23,322 Less Arrow 20,300
Total assets 157,355 More Arrow 176,950 Less Arrow 163,924
Current assets 154,146 More Arrow 173,353 Less Arrow 160,033
Current liabilities 96,808 More Arrow 119,805 Less Arrow 111,328
Equity capital 60,546 Less Arrow 57,145 Less Arrow 52,299
- share capital 15,879 Less Arrow 15,082 Less Arrow 14,155
Employees (average) 75 Equal arrow 75 Equal arrow 75

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 38.5% Less Arrow 32.3% Less Arrow 31.9%
Turnover per employee 11,612 Less Arrow 9,542 Less Arrow 8,310
Profit as a percentage of turnover 3.0% More Arrow 3.3% Equal arrow 3.3%
Return on assets (ROA)
Current ratio 159.2% Less Arrow 144.7% Less Arrow 143.7%
Return on equity (ROE) 42.7% Less Arrow 40.8% Less Arrow 38.8%
Change turnover 117,496 Less Arrow 51,572 Less Arrow -7,913
Change turnover % 16% Less Arrow 8% Less Arrow -1%
Chg. No. of employees 0 Equal arrow 0 Equal arrow 0
Chg. No. of employees % 0% Equal arrow 0% Equal arrow 0%

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.